solifenacin succinate

A muscarinic receptor antagonist drug used for treating contraction of overactive bladder such as incontinence, urinary frequency, and urgency. Solifenacin is a competitive cholinergic receptor antagonist, selective for the M3 receptor subtype. It was manufactured and marketed by Astellas, GlaxoSmithKline and Teva Pharmaceutical Industries.[ Reference standards of Solifenacin Succinate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Solifenacin Nitroso Impurity
    [catalogue_number] => PA 19 0501012
    [category_ids] => ,70,75,76,78,82,162,
    [chemical_name] => 
    [weight] => 238.29
    [form] => C15H14N2O
    [cas] => NA
    [pslug] => solifenacin-nitroso-impurity-pa190501012
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)